Lichen International (LICN) Cash & Equivalents (2021 - 2025)

Lichen International (LICN) has reported Cash & Equivalents for 5 consecutive years, with $26.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Equivalents rose 0.76% year-over-year to $26.9 million; the TTM figure through Dec 2025 stood at $26.9 million (up 0.76% YoY), while the FY2025 annual figure was $26.9 million, up 0.76% from the prior year.
• Cash & Equivalents climbed to $26.9 million in Q4 2025 per LICN's latest filing, from $22.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $34.2 million in Q2 2024 and bottomed at $16.8 million in Q4 2021.
• Historically, Cash & Equivalents has averaged $24.3 million across 5 years, with a median of $24.2 million in 2022.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 81.73% — and 2025, when it tumbled 33.97%.
• Lichen International's Cash & Equivalents stood at $16.8 million in 2021, then soared by 34.16% to $22.6 million in 2022, then grew by 14.41% to $25.9 million in 2023, then gained by 3.31% to $26.7 million in 2024, then gained by 0.76% to $26.9 million in 2025.
• Business Quant data shows LICN's Cash & Equivalents at $26.9 million in Q4 2025, $22.6 million in Q2 2025, and $26.7 million in Q4 2024.